These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16333855

  • 1. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ, McKinney MM, Carpenter WR.
    Cancer; 2006 Jan 01; 106(1):180-7. PubMed ID: 16333855
    [Abstract] [Full Text] [Related]

  • 2. Strategic approaches to cancer control research in NCI-funded research bases.
    McKinney MM, Warnecke RB, Kaluzny AD.
    Cancer Detect Prev; 1992 Jan 01; 16(5-6):329-35. PubMed ID: 1473121
    [Abstract] [Full Text] [Related]

  • 3. The effects of managed care and competition on community-based clinical research.
    Carpenter WR, Weiner BJ, Kaluzny AD, Domino ME, Lee SY.
    Med Care; 2006 Jul 01; 44(7):671-9. PubMed ID: 16799362
    [Abstract] [Full Text] [Related]

  • 4. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM.
    J Clin Oncol; 2005 Sep 20; 23(27):6682-9. PubMed ID: 16170176
    [Abstract] [Full Text] [Related]

  • 5. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
    McKinney MM, Weiner BJ, Wang V.
    Oncol Nurs Forum; 2006 Sep 01; 33(5):951-9. PubMed ID: 16955123
    [Abstract] [Full Text] [Related]

  • 6. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM.
    J Clin Oncol; 2005 Aug 01; 23(22):5247-54. PubMed ID: 16051967
    [Abstract] [Full Text] [Related]

  • 7. Cancer control research for community programs: the National Cancer Institute initiative.
    Hunter CP, Bavier AR, Ford LG.
    Cancer Detect Prev; 1990 Aug 01; 14(6):633-7. PubMed ID: 2257561
    [Abstract] [Full Text] [Related]

  • 8. Interorganizational exchanges as performance markers in a community cancer network.
    McKinney MM, Morrissey JP, Kaluzny AD.
    Health Serv Res; 1993 Oct 01; 28(4):459-78. PubMed ID: 8407338
    [Abstract] [Full Text] [Related]

  • 9. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H.
    Gan To Kagaku Ryoho; 2000 Jul 01; 27(8):1144-51. PubMed ID: 10945009
    [Abstract] [Full Text] [Related]

  • 10. Ecological analysis of the first generation of community clinical oncology programs.
    Schopler JH.
    Health Serv Res; 1993 Apr 01; 28(1):69-95. PubMed ID: 8463110
    [Abstract] [Full Text] [Related]

  • 11. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
    Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik E, Ford L.
    Cancer Epidemiol Biomarkers Prev; 1994 Apr 01; 3(3):261-9. PubMed ID: 8019377
    [Abstract] [Full Text] [Related]

  • 12. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD, Lacey LM, Warnecke R, Hynes DM, Morrissey J, Ford L, Sondik E.
    Health Serv Res; 1993 Jun 01; 28(2):159-82. PubMed ID: 8514498
    [Abstract] [Full Text] [Related]

  • 13. Delaware/Christiana Care Community Clinical Oncology Program (CCOP): a National Cancer Institute clinical trials program.
    Price K.
    Del Med J; 2007 Jun 01; 79(6):247-51. PubMed ID: 17621871
    [No Abstract] [Full Text] [Related]

  • 14. Implementing a cancer-control study in a National Cancer Institute clinical trials network.
    Labuhn KT, Valanis BG, Glass AG, Vollmer WM.
    Cancer Pract; 1994 Jun 01; 2(1):47-54. PubMed ID: 8055006
    [Abstract] [Full Text] [Related]

  • 15. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM, Hynes DM, Kaluzny AD.
    J Health Hum Resour Adm; 1992 Jun 01; 14(3):307-26. PubMed ID: 10118501
    [Abstract] [Full Text] [Related]

  • 16. Organizations and structures that facilitate community research.
    Coltman CA.
    Semin Oncol; 1994 Aug 01; 21(4 Suppl 7):107-11. PubMed ID: 8091235
    [Abstract] [Full Text] [Related]

  • 17. Development of cancer cooperative groups in Japan.
    Fukuda H.
    Jpn J Clin Oncol; 2010 Sep 01; 40(9):881-90. PubMed ID: 20670961
    [Abstract] [Full Text] [Related]

  • 18. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM, Sandler AB.
    J Clin Oncol; 2006 Oct 01; 24(28):4545-52. PubMed ID: 17008693
    [Abstract] [Full Text] [Related]

  • 19. Funding patient-reported outcomes in cancer clinical trials.
    Moinpour CM, Denicoff AM, Bruner DW, Kornblith AB, Land SR, O'Mara A, Trimble E.
    J Clin Oncol; 2007 Nov 10; 25(32):5100-5. PubMed ID: 17991928
    [Abstract] [Full Text] [Related]

  • 20. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
    Lyss AP, Lilenbaum RC.
    Clin Lung Cancer; 2009 Nov 10; 10(6):410-3. PubMed ID: 19900858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.